{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:29:35Z","timestamp":1772821775696,"version":"3.50.1"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"12","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2020,11,17]]},"abstract":"<jats:p>Few studies have compared the clinical efficacy and adverse events of combined antiretroviral therapy (cART) regimens in pregnant women seeking obstetrical care. The objective of this study was to compare the efficacy (virus load response), adverse events, and obstetrical and neonatal outcomes of three different regimens of cART in HIV-infected pregnant women initiating treatment in Rio de Janeiro, Brazil. This was a retrospective cohort study of cART-naive pregnant women who initiated either ritonavir-boosted protease inhibitors (atazanavir or lopinavir), efavirenz, or raltegravir plus a backbone regimen.<\/jats:p>","DOI":"10.1128\/aac.01068-20","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T13:43:48Z","timestamp":1601473428000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of Three Antiretroviral Regimens Initiated during Pregnancy: Clinical Experience in Rio de Janeiro"],"prefix":"10.1128","volume":"64","author":[{"given":"Maria de Lourdes","family":"Benamor Teixeira","sequence":"first","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"},{"name":"Instituto Nacional de Infectologia Evandro Chagas, Funda\u00e7\u00e3o Oswaldo Cruz, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevon L.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"Fragoso Da Silveira Gouv\u00eaa","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"},{"name":"Instituto Nacional de Infectologia Evandro Chagas, Funda\u00e7\u00e3o Oswaldo Cruz, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Let\u00edcia","family":"Santos Cruz","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loredana","family":"Ceci","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fellipe","family":"Pinheiro Lattanzi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon Claude","family":"Sidi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallace","family":"Mendes-Silva","sequence":"additional","affiliation":[{"name":"Maternity-Fetal Department and Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Nielsen-Saines","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2412-0627","authenticated-orcid":false,"given":"Esau Custodio","family":"Joao","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"The global HIV\/AIDS epidemic\u2014data and trends: global statistics","author":"U.S. Department of Health and Human Services","year":"2020","unstructured":"U.S. Department of Health and Human Services. 2020. The global HIV\/AIDS epidemic\u2014data and trends: global statistics. U.S. Department of Health and Human Services, Washington, DC. https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/global-statistics. Accessed 22 September 2020."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780190924775.001.0001","volume-title":"Bartlett\u2019s medical management of HIV infection","author":"Bartlett J","year":"2019","unstructured":"Bartlett J, Redfield R, Pham P. 2019. Bartlett\u2019s medical management of HIV infection. Oxford University Press, Oxford, United Kingdom."},{"key":"e_1_3_2_4_2","volume-title":"Management of HIV Infection in pregnancy and postpartum 2018 (2019 interim update)","author":"British HIV Association","year":"2019","unstructured":"British HIV Association. 2019. Management of HIV Infection in pregnancy and postpartum 2018 (2019 interim update). BHIVA, London, United Kingdom."},{"key":"e_1_3_2_5_2","unstructured":"WHO. 2018. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines. Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_6_2","volume-title":"Panel on Antiretroviral Guidelines for Adults and Adolescents: guidelines for the use of antiretroviral agents in adults and adolescents with HIV","author":"AIDSInfo","year":"2019","unstructured":"AIDSInfo. 2019. Panel on Antiretroviral Guidelines for Adults and Adolescents: guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services, Washington, DC."},{"key":"e_1_3_2_7_2","volume-title":"Guidelines, version 9.1","author":"European AIDS Clinical Society","year":"2018","unstructured":"European AIDS Clinical Society. 2018. Guidelines, version 9.1. EACS, Brussels, Belgium."},{"key":"e_1_3_2_8_2","volume-title":"Clinical Protocol and Treatment Guidelines for Care of Infection with HIV in Adults","author":"Ministry of Health of Brazil","year":"2018","unstructured":"Ministry of Health of Brazil. 2018. Clinical Protocol and Treatment Guidelines for Care of Infection with HIV in Adults. Department of Chronic Diseases and Sexually Transmitted Infections, Brasilia, Brazil."},{"key":"e_1_3_2_9_2","volume-title":"HIV\/AIDS fact sheet","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. HIV\/AIDS fact sheet. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(16)30087-X"},{"key":"e_1_3_2_11_2","volume-title":"Johns Hopkins HIV guide: management of HIV infection and its complications","author":"Gallant J","year":"2012","unstructured":"Gallant J, Pham P. 2012. Johns Hopkins HIV guide: management of HIV infection and its complications. Johns Hopkins Medicine, Baltimore, MD."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1415-790X2007000300004"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000212"},{"key":"e_1_3_2_14_2","first-page":"1715","article-title":"No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception","volume":"61","author":"Mandelbrot L","year":"2015","unstructured":"Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S. 2015. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception. Clin Infect Dis 61:1715\u20131725.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_2_15_2","unstructured":"Mirochnick M Shapiro DE Morrison L Frenkel L Chakhtoura N Siberry GK Best B Cruz MLS Mmbaga Bt Pilotto JHS Violari A Prommas S Jo\u00e3o Filho EC. 2019 Randomized trial of raltegravir-ART versus efavirenz-ART when initiated during pregnancy 3960 abstr CROI 2019. CROI Seattle WA."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30038-2"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2018.1459343"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002895"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30050-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60918-1"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.12.052"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv183"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189851"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1086\/427192"},{"key":"e_1_3_2_25_2","first-page":"521","article-title":"Risk factors for adverse birth outcomes in the PROMISE 1077BF\/1077FF trial","volume":"81","author":"Sebikari D","year":"2019","unstructured":"Sebikari D, Farhad M, Fenton T, Owor M, Stringer JSA, Qin M, Chakhtoura N, Chi BH, Saidi F, Nevrekar N, Violari A, Chipato T, McIntyre JA, Moodley D, Taha TE, Theron G, Fowler MG. 2019. Risk factors for adverse birth outcomes in the PROMISE 1077BF\/1077FF trial. J AIDS 81:521\u2013532.","journal-title":"J AIDS"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2020.1755011"},{"key":"e_1_3_2_27_2","volume-title":"Algoritmo Brasileiro Vers\u00e3o 13","author":"Departamento de DST\/Aids e Heptites Virais","year":"2015","unstructured":"Departamento de DST\/Aids e Heptites Virais. 2015. Algoritmo Brasileiro Vers\u00e3o 13. Ministerio da Saude, Brasilia, Brazil."},{"key":"e_1_3_2_28_2","volume-title":"Clinical protocol and treatment guidelines for the prevention of vertical transmission of HIV, syphilis, and viral hepatitis","author":"Ministry of Health of Brazil","year":"2019","unstructured":"Ministry of Health of Brazil. 2019. Clinical protocol and treatment guidelines for the prevention of vertical transmission of HIV, syphilis, and viral hepatitis. Department of Chronic Diseases and Sexually Transmitted Infections, Brasilia, Brazil."},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/64.4.650"},{"key":"e_1_3_2_30_2","volume-title":"Fundamentals of Biostatistics","author":"Rosner B","year":"2011","unstructured":"Rosner B. 2011. Fundamentals of Biostatistics, 7th ed. Brooks\/Cole, Boston, MA."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01068-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01068-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:38:19Z","timestamp":1645479499000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01068-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,11,17]]}},"alternative-id":["10.1128\/AAC.01068-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01068-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"2020-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01068-20"}}